Oculotect Unidoses (Povidone K25)

Povidone K25, the active ingredient in Oculotect Unidoses, is an excipient presented as a sterile ophthalmic solution for ocular use. It functions as a viscosity enhancer and stabilizer in eye drop formulations, supporting comfort and protection of the ocular surface. GNH USA supplies Oculotect Unidoses as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Oculotect Unidoses, containing povidone K25, is employed as a viscosity‑enhancing and stabilizing agent in ophthalmic formulations.

Dry eye syndrome: provides lubrication and prolongs tear‑film stability, reducing discomfort. Post‑operative ocular care: helps maintain corneal hydration and patient comfort after eye surgery. Contact lens wear: reduces irritation by forming a protective, moist film over the lens and ocular surface.

Oculotect Unidoses is generally well tolerated, but ocular preparations can cause local reactions.

Common Side Effects: - Transient ocular irritation or stinging upon instillation. - Temporary blurred vision that resolves within minutes. - Mild conjunctival redness. - Slight tearing or discharge. - Mild itching sensation. - Sensation of foreign body in the eye.

Serious or Rare Side Effects: - Allergic conjunctivitis with swelling and intense redness. - Corneal edema or infiltrates. - Severe hypersensitivity reaction, including angio‑edema of the eyelids. - Persistent pain or photophobia. - Vision loss not attributable to underlying disease. - Systemic allergic response such as urticaria.

When using Oculotect Unidoses, consider the following precautions to ensure safety and efficacy.

Allergy assessment: verify that the patient has no known hypersensitivity to povidone or related polymers. Aseptic technique: use sterile drops and avoid contaminating the container to prevent infection. Monitor irritation: discontinue use and seek medical advice if severe redness, pain, or vision changes occur. Pediatric use: administer only under specialist supervision, adjusting frequency as appropriate. Pregnancy and lactation: evaluate risk‑benefit ratio, as systemic absorption is minimal but data are limited. Store at room temperature: keep in the original container, protect from light and moisture, and discard after the indicated period after opening.

Oculotect Unidoses may interact with other ophthalmic products, affecting tolerance or efficacy.

Major Interactions (Avoid): - Concurrent use with preservative‑containing eye drops: may increase ocular irritation. - Co‑administration with topical anesthetics: risk of additive corneal toxicity.

Moderate Interactions (Monitor Closely): - Systemic antihistamines: can reduce tear production, potentially diminishing lubricating effect. - Topical corticosteroids: may mask signs of irritation, requiring close observation. - Other viscosity‑enhancing agents: may lead to excessive thickness of the tear film, causing blurred vision.